HLA Typing For Transplant Market Report
RA00323
HLA Typing for Transplant Market, by Technology (Non-Molecular Assay, Molecular Assay, Next Generation Sequencing, Sanger’s Sequencing), Product (Instruments, Reagents & Consumables, Software & Services), Application (Diagnostics and Research), End-User (Hospitals, Academic & Research Institutes, Commercial Service Providers): Global Opportunity Analysis and Industry Forecast, 2020–2027
pandemic has shown to have an enormous impact
on most
industries.
Click Here to access our comprehensive analysis of the
Impact of covid-19 on HLA Typing For Transplant Market
The global HLA typing for the transplant market will witness significant growth due to a rise in the amount of transplant procedures and an increase in technological advancements in the field of HLA typing.
HLA Typing for Transplant Market, Analysis:
Human leukocyte antigen (HLA) typing is often used to match blood cells or bone marrow transplant of patient’s with donors. As transplant complications increase, there is a growing urgency to balance the viability of organ transplantation before the surgery to prevent any damage. Matching HLA assists to grow and develop new blood cells and eliminates the risk of adverse effects after transplantation.
Growth in research & development is expected to drive the global HLA typing for the transplant market
Increasing R&D activities in the pharmaceutical and biotechnology industry are attributing the market growth for the global HLA typing for the transplant market. An increasing number of resources invested by the government, as well as the private business firms in the global HLA typing market, are equally contributing towards the market growth.
Unfavorable policy for an organ transplant is anticipated to restrain the growth of global HLA typing for the transplant market
Strict government regulations for organ donations and transplantation could hamper market growth. In addition, organ transplant devices are very expensive, and there are only a few organ donations and transplantation centers, these factors restrain the growth of the global HLA typing for the transplant market.
Technological innovations are anticipated to create enormous opportunities for global HLA typing for the transplant market
Technological advancements will further create several opportunities for propelling development in the global HLA typing for the transplant market. Advancement in health care facilities around developing countries poses significant business growth prospects for the market. In addition, growing public-private investment for product innovation is also anticipated to generate enormous opportunities for the market.
HLA Typing for Transplant Market, by Technology:
The molecular assay will be most lucrative till 2027
By technology, the HLA typing for the transplant market is divided into the non-molecular assay, molecular assay, next-generation sequencing, and sanger’s sequencing. Amongst these, molecular assay dominates the market share and is expected to continue till 2027. This is due to various benefits offered by molecular assays such as small processing time, high procedural efficiency, multi-sample test, and real-time data interpretation.
HLA Typing for Transplant Market, by Product & Services:
Instruments segment will be most lucrative till 2027
By product & service, the HLA typing for the transplant market is segmented into instruments, reagents & consumables, and software & services. Out of these, the instrument segment has the largest market share attributing to the rising usage of developed instruments, which assists in providing better and accurate results.
HLA Typing for Transplant Market, by Applications:
Diagnostic application is estimated to dominate the HLA typing for transplant market
By application, the HLA typing for the transplant market is classified into diagnostics and research. Diagnostic application is used to match organ and transplantation donors with patients. It has the largest market share, as this technique is used commonly. In addition, an increasing number of organ donations and transplants will contribute towards market growth.
HLA Typing for Transplant Market, by End-Users:
Hospital is estimated to be the highest growing till 2027
By end-users, the HLA typing for the transplant market is bifurcated into hospitals, academic & research institutes, and commercial service providers. Amongst these, the hospital sector dominated the market share and is anticipated to continue until 2027. The hospital sector leads the market due to the availability of advanced medical equipment and skilled personnel that enables treating patients efficiently and provides accurate results on time. HLA typing for transplant is more commonly used in hospitals and health sectors than other end-users owing to its increasing number of the patient count with the rising population.
HLA Typing for Transplant Market, by Region:
Asia-Pacific region will have lucrative opportunities for the market investors
The global HLA typing for the transplant market is analyzed across North America, Europe, Asia-Pacific, and LAMEA regions. North America dominates the market share of the HLA typing for the transplant market owing to the increasing number of organ transplant procedures and rising life expectancy rates. Asia-Pacific is anticipated to be the fastest-growing region due to the increasing adoption of advanced technology and medical devices.
To explore more about Global HLA Typing for Transplant Market, get in touch with our analysts here.
https://www.researchdive.com/connect-to-analyst/323
Key Participants in the Global HLA Typing for Transplant Market:
Merger & acquisition and advanced product development are the frequent strategies followed by the market players
Some of the major key players in the global HLA typing for transplant market are Thermo Fisher Scientific, Qiagen, Illumina Inc., CareDx Inc., Immucor Inc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc., Luminex Co., Biofortuna, and others.
Market Players prefer inorganic growth strategies to expand into local markets.HLA typing for transplant market players are emphasizing more on merger & acquisition and advanced product development. These are the various strategies followed by established organizations. To emphasize more on the competitor analysis of market players,Porter’s five forces model is explained in the report.
Aspect |
Particulars |
Historical Market Estimations |
2018-2019 |
Base Year for Market Estimation |
2019 |
Forecast timeline for Market Projection |
2020-2027 |
Geographical Scope |
North America, Europe, Asia-Pacific, LAMEA |
Segmentation by Technology |
|
Segmentation by Product & Service |
|
Segmentation by Application |
|
Segmentation by End-User |
|
Key Countries Covered |
U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia |
Key Companies Profiled |
|
Source: Research Dive Analysis
Q1. Which are the leading companies in the global HLA typing for the transplant market?
A. Thermo Fisher Scientific, Qiagen, and Illumina Inc. are some of the key players in the global HLA typing for the transplant market.
Q2. Which region possesses greater investment opportunities in the coming future?
A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q3. What are the strategies opted by the leading players in this market?
A. Technological advancements, product development, along with joint ventures, are the key strategies opted by the operating companies in this market.
Q4. Which companies are investing more in R&D practices?
A. CareDx Inc., Immucor Inc and Bio-Rad Laboratories Inc. are the companies investing more in R&D activities for developing new products and technologies.
Research Methodology
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com